Hide Board Information

Show Board Information

Aralez Pharmaceuticals Inc. ARLZQ

Board Mod: Add me as mod

Asst Mods:

Last Post: 07/23/2018 4:17:29 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 4

ARLZ


Aralez Pharmaceuticals Inc.

Aralez Pharmaceuticals Inc. (OTCMRKTS: ARLZQ) Stock Message Board

1. ARLZQ Company Profile

    

2. ARLZQ Time & Sales

    

3. ARLZQ Recent News

    

4. ARLZQ Filings

    

5. ARLZQ Financials

    

6. ARLZQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	36% 5.4M C.4287 even more vol today!!! Who has	znewcar1	07/23/2018 4:17:29 PM
5	Nice upturn there z.	PoemStone	07/21/2018 11:33:37 AM
4	25% 3.6M C.315 oversold? dead cat bounce?	znewcar1	07/20/2018 4:07:34 PM
3	8% 4.5M C.462 H.5 WL has potential to back	znewcar1	06/13/2018 4:23:03 PM
2	14% 7.7M C.5027 h.5279 rock steady	znewcar1	05/11/2018 4:54:20 PM
1	md 6% dip and ripping to hod$.49 it get vol then	znewcar1	05/11/2018 12:20:56 PM

Recent Articles

• Exploring AI Innovations from Runway and Impact on Entertainment
• Key Updates on Class Actions Involving Neogen and Others
• Allegiant Expands Network with Exciting New Nonstop Flights
• Investors Target Hims & Hers and Sarepta Through Legal Action
• Hercules Metals Secures $15 Million Financing for Growth
• Argo Blockchain Faces Nasdaq Delisting, Seeks Hearing
• Transforming $100 into Significant Returns with Microsoft Stock
• Pacific Valley Bancorp Sees Growth Despite Challenges
• Understanding Legal Actions Against Flywire Corporation's Management
• Pacific Valley Bancorp's Q2 2025 Financial Performance Insights
• STIHL TIMBERSPORTS® Championship Showcases New Records and Stars
• Market Dynamics: Understanding the Impact of the Dollar Surge
• QCI's Rebirth: Embracing Innovators and Casino Technology
• Unlocking Competitiveness in Wind and Solar Energy Futures
• Apellis Pharmaceuticals Receives FDA Approval for EMPAVELI®
• Understanding Recent Developments in Flywire Corporation's Legal Affairs
• Current Job Market Woes for Graduates: Navigating Challenges Ahead
• Reckitt Benckiser Faces Class Action Lawsuit Over Infant Formula Safety
• Legal Actions To Safeguard Investor Interests in Tempus & Vestis
• Investing in argenx: A 5-Year Journey of Growth and Value
• Top Stocks Increasing Buybacks after Strong Earnings Performance
• Unlocking America's Technological Future: Key Resources Revealed
• North Park University Nursing Student Achieves Key Fellowship
• Mary Kay’s New Electric Cadillac: A Bold Step Forward
• Elevate Your Muscle Growth: The Power of CrazyBulk Supplements
• How a $1000 Investment in Parker Hannifin Thrived Over Time
• Understanding the Investor Avenues with Sarepta Therapeutics
• Innovative Report Highlights Renewable Energy's Viability
• The Transformative Power of Investing: A 15-Year Journey With NSIT
• UnitedHealth Group Faces Class Action as Lawsuit is Filed
• Court Ruling Challenges SEC's Funding of Data Collection Schemes
• Class Action Lawsuits Highlight Pressures on Bitfarms and Reddit
• Why Regional Health Properties Shareholders Should Embrace Merger
• Sable Offshore Corp. Class Action Lawsuit: Investor Alert
• Investigation Launched into Allianz Life Insurance Data Breach
• Discovering the Growth of Sprouts Farmers Market Stock Over a Decade
• Lowe's CEO Emphasizes Job Security through Skilled Trades
• Invesque Inc. Transitions Management and Sells 11 Assets
• Kansas City Life Insurance Company Announces Dividend Payment
• Exploring Potential Violations for Foot Locker, Enzo, and Hudson
• Kansas City Life Announces Latest Quarterly Dividends and Growth
• Quiddity Engineering Welcomes Minh Tran as New Senior Manager
• Investors at SOC Can Take Action in Class Action Lawsuit
• Investor Alert: GeneDx Holdings Faces Class Action Investigation
• Exploring Shareholder Rights Amid Major Company Mergers
• Earnings Ahead: Key Insights on Major Tech Stocks This Week
• D-Wave Quantum and Partners: Innovating the Future of Computing
• Sarepta Therapeutics Gains Ground After FDA's Elevidys Clearance
• Celestica's Stock Growth: Q2 Earnings and 2025 Projections
• Enhancing Digital Connectivity in El Salvador with Tigo and Partners